Criteria Used by Health Professionals on the Selection of Allergen Immunotherapy in Real Clinical Practice

NCT04038268 | Completed

• 1 other identifier: RECHMPL19_0361
• Study Type: observational
• Target: 400
• Locations: 1 country
• Sites: 1

Brief Summary

Background : Allergen Immunotherapy (AIT) is the only etiological treatment for allergic respiratory diseases. In order to improve the competence on the use of AIT, it is important to extend the investigator's knowledge on its use in routine clinical practice, outside the experimental setting of clinical trials, in real life population of patients receiving AIT. Objective: To evaluate the clinical criteria used by treating clinicians and by the patients themselves, when establishing AIT as treatment in a patient with respiratory disease caused by an IgE-dependent-hypersensitivity to aeroallergens Methods: In 6 country (Denmark, France, Germany, Norway, Spain \& Sweden), the national coordinator will be directly responsible for selection of Survey Doctor's participants (Investigators). During 12 months:

• Firstly, each investigator will complete the Survey Doctor, online, on SurveyMonkey platform to explain what are the key drivers in Allergen Immunotherapy (AIT) selection (Doctors' Questionnaire, DQ).
• On the other hand, at each AIT prescription to a patient, doctors will complete the Survey Patient, on the same platform, to explain how and why they have chosen this type of AIT (Patients' Questionnaire, PQ).

Conditions

Allergen Immunotherapy

Keywords

Immunotherapy; Real Clinical Practice; Respiratory disease; Aeroallergens; IgE-dependent hypersensitivity

Outcome Measures

Primary Outcomes (1)

• Clinical criteria in AIT

  Clinical criteria used by treating clinicians and by the patients themselves, when establishing AIT as treatment in a patient with respiratory disease. These are called "drivers of prescription". caused by an IgE-dependent-hypersensitivity to aeroallergens Among the different criteria selected by participants, order of priority of AIT drivers will be established

  1 day

Study Arms (2)

Patients

Adults and children, males and females, with IgE mediated pollen, house dust mites, animal dander and moulds respiratory allergy who will initiate aeroallergen AIT, either SCIT, SLIT-drops or SLIT-tablets according to real life clinical standards of practice

Prescribers

Doctors who are currently prescribing AIT as part of their regular clinical practice

Eligibility Criteria

• Age: 5 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with IgE mediated hypersensitivity to aeroallergens who will initiate AIT, either SCIT, SLIT-drops or SLIT-tablets according to real life clinical standards of practice

You may qualify if:

• Patients with IgE mediated respiratory allergy
• Patients who will initiate any type of aeroallergen AIT according to real life clinical standards of practice
• Any type of aeroallergen for AIT will be included : pollen, house dust mite, animal, dander, moulds
• Patient who is under the care of the Doctor participating in the survey

You may not qualify if:

• Patients who refuse to give their informed consent
• Food immunotherapy
• Venom Immunotherapy

Sponsors & Collaborators

• University Hospital, Montpellier: lead

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Respiration Disorders

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Study Officials

• Pascal Demoly

  University Hospital, Montpellier

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 12, 2019
• First Posted: July 30, 2019
• Study Start: September 1, 2019
• Primary Completion: September 30, 2020
• Study Completion: September 30, 2020
• Last Updated: December 29, 2020

Record last verified: 2020-12

Locations

FR (1)